MLYS logo

Mineralys Therapeutics (MLYS)

Profile

Full Name

Mineralys Therapeutics, Inc.

Ticker Symbol

MLYS

Exchange

NASDAQ

Country

United States

IPO

February 10, 2023

Indexes

Not included

Employees

51

Key Details

Price

$12.24

Market Cap

$768.65M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

-$3.66(-83.92% YoY)

PE Ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Apr 2, 25 HC Wainwright & Co.
Buy
Mar 10, 25 HC Wainwright & Co.
Buy
Feb 24, 25 Guggenheim
Buy
Feb 13, 25 HC Wainwright & Co.
Buy
Feb 13, 25 Goldman Sachs
Buy
Nov 12, 24 HC Wainwright & Co.
Buy
Oct 31, 24 HC Wainwright & Co.
Buy
Aug 15, 24 HC Wainwright & Co.
Buy
Jul 10, 24 HC Wainwright & Co.
Buy
Apr 2, 24 Goldman Sachs
Buy

Institutional Ownership

  • What is the ticker symbol for Mineralys Therapeutics?
  • Does Mineralys Therapeutics pay dividends?
  • What sector is Mineralys Therapeutics in?
  • What industry is Mineralys Therapeutics in?
  • What country is Mineralys Therapeutics based in?
  • When did Mineralys Therapeutics go public?
  • Is Mineralys Therapeutics in the S&P 500?
  • Is Mineralys Therapeutics in the NASDAQ 100?
  • Is Mineralys Therapeutics in the Dow Jones?
  • When was Mineralys Therapeutics's last earnings report?
  • When does Mineralys Therapeutics report earnings?
  • Should I buy Mineralys Therapeutics stock now?

What is the ticker symbol for Mineralys Therapeutics?

The ticker symbol for Mineralys Therapeutics is NASDAQ:MLYS

Does Mineralys Therapeutics pay dividends?

No, Mineralys Therapeutics does not pay dividends

What sector is Mineralys Therapeutics in?

Mineralys Therapeutics is in the Healthcare sector

What industry is Mineralys Therapeutics in?

Mineralys Therapeutics is in the Biotechnology industry

What country is Mineralys Therapeutics based in?

Mineralys Therapeutics is headquartered in United States

When did Mineralys Therapeutics go public?

Mineralys Therapeutics's initial public offering (IPO) was on February 10, 2023

Is Mineralys Therapeutics in the S&P 500?

No, Mineralys Therapeutics is not included in the S&P 500 index

Is Mineralys Therapeutics in the NASDAQ 100?

No, Mineralys Therapeutics is not included in the NASDAQ 100 index

Is Mineralys Therapeutics in the Dow Jones?

No, Mineralys Therapeutics is not included in the Dow Jones index

When was Mineralys Therapeutics's last earnings report?

Mineralys Therapeutics's most recent earnings report was on Feb 12, 2025

When does Mineralys Therapeutics report earnings?

The next expected earnings date for Mineralys Therapeutics is May 9, 2025

Should I buy Mineralys Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page